{"url_path":"/sec/sgmo/10-k/2026/item-16","section_key":"item-16","section_title":"Item 16 FORM 10-K SUMMARY","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-03-30","source_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","accession_number":"0001628280-26-022029","cik":"0001001233","ticker":"SGMO","issuer_name":"SANGAMO THERAPEUTICS, INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1001233/0001628280-26-022029-index.html","primary_entity_key":"0001001233","primary_entity_name":"SANGAMO THERAPEUTICS, INC"},"word_count":434,"has_tables":true,"body_markdown":"ITEM 16 – FORM 10-K SUMMARY\n\nNone.\n\n150\n\n[Table of Contents](#i29aeb4416f69482f8f7bc32e0d48731a_7)\n\nSIGNATURES\n\nPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on March 30, 2026.\n\nDate: March 30, 2026\n\nSANGAMO THERAPEUTICS, INC.\n\nBy:\n/ S /    ALEXANDER D. MACRAE\n\nAlexander D. Macrae\n\nPresident and Chief Executive Officer\n\nKNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Alexander D. Macrae and Scott Willoughby, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.\n\nPursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:\n\nSignatureTitleDate\n\n/ S /    ALEXANDER D. MACRAE\nPresident, Chief Executive Officer\n(Principal Executive Officer) and DirectorMarch 30, 2026\n\nAlexander D. Macrae, M.B., Ch.B., Ph.D.\n\n/ S /    NIKUNJ JAINInterim Chief Financial Officer\n(Principal Financial and Accounting Officer)March 30, 2026\n\nNikunj Jain\n\n/ S /    H. STEWART PARKER\nDirector and Chair of the BoardMarch 30, 2026\n\nH. Stewart Parker\n\n/ S /    COURTNEY BEERS\nDirectorMarch 30, 2026\n\nCourtney Beers, Ph.D.\n\n/ S /   ROBERT F. CAREYDirectorMarch 30, 2026\n\nRobert F. Carey\n\n/ S /    KENNETH J. HILLAN\nDirectorMarch 30, 2026\n\nKenneth J. Hillan, M.B., Ch.B.\n\n/ S /   MARGARET A. HORN\nDirectorMarch 30, 2026\n\nMargaret A. Horn, J.D.\n\n/ S /    JOHN H. MARKELS\nDirectorMarch 30, 2026\n\nJohn H. Markels, Ph.D.\n\n/ S /    JAMES R. MEYERS\nDirectorMarch 30, 2026\n\nJames R. Meyers\n\n/ S /    KAREN L. SMITH\nDirectorMarch 30, 2026\n\nKaren L. Smith, M.D., Ph.D., M.B.A., L.L.M."}